Risk of breast cancer in a cohort of infertile women

Gynecologic Oncology

Volumn 60, Issue 1, 1996, Pages 3-7

  Rossing, Mary Anne ^a,b   Daling, Janet R ^a,b   Weiss, Noel S ^a,b   Moore, Donald E ^c   Self, Steven G ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVULATION INDUCTION; PRIORITY JOURNAL;

EID: 0030069080     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0002     Document Type: Article

References (17)

1. Wysowski, D. K. Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril. 60: 1096-1098 (1993).
2. Fischel, S., and Jackson, P. Follicular stimulation for high tech pregnancies: Are we playing it safe? Br. Med. J. 299, 309-311 (1989).
3. Sutherland, R. L., Watts, C. K. W., Hall, R. E., and Ruenitz, P. C. Mechanisms of growth inhibition by nonsteroidal antiestrogens in human breast cancer cells, J. Steroid Biochem. 27, 891-897 (1987).
4. Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., and Self, S. G. Ovarian tumors in a cohort of infertile women, N. Engl. J. Med. 331, 771-776 (1994).
5. Breslow, N. E., and Day, N. E. Statistical methods in cancer research. Vol 2. The design and analysis of cohort studies, IARC Scientific Publications No. 82, International Agency for Research on Cancer, Lyon, France (1987).
6. Preston, D. L., Lubin, J. H., Pierce, D. A., et al. EPICURE User's Guide, Hirosoft International Corp., Seattle, WA (1993).
7. Cowan, L. D., Gordis, L., Tonascia, J. A., and Jones, G. S. Breast cancer incidence in women with a history of progesterone deficiency, Am. J. Epidemiol 114, 209-217 (1981).
8. Ron, E., Lunenfeld, B., Menczer, J., et al Cancer incidence of a cohort of infertile women, Am. J. Epidemiol. 125, 780-790 (1987).
9. Brinton, L. A., Melton, L. J., Malkasian, G. D., Bond, A., and Hoover, R. Cancer risk after evaluation for infertility, Am. J. Epidemiol. 129, 712-722 (1989).
10. Gammon, M. D., and Thompson, W. D. Infertility and breast cancer: A population-based case-control study, Am. J. Epidemiol. 132, 708-716 (1990).
11. Brzezinski, A., Peretz, T., Mor-Yosef, S., and Schenker, J. G. Ovarian stimulation and breast cancer: Is there a link? Gynecol. Oncol. 52, 292-295 (1994).
12. Clark, J. H., and Markaverich, B. M. The agonist - antagonist properties of clomiphene: A review, Pharmac. Ther. 15, 467-519 (1982).
13. McKenna, M., and Pepperell, R. J. Anti-estrogens: Their clinical physiology and use in reproductive medicine, Baillieres Clin. Obstet. Gynaecol. 2, 545-565 (1988).
14. Bush, T. L., and Helzlsouer, K. J. Tamoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial. Epidemiol. Rev. 15, 233-243 (1993).
15. Lerner, L. J., and Jordan, V. C. Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award lecture, Cancer Res. 50, 4177-4189 (1990).
16. Hecker, E., Vegh, I., Levy, C. M., et al. Clinical trial of clomiphene in advanced breast cancer, Eur. J. Cancer 10, 747-749 (1974).
17. Kaufman, S. C., Spirtas, R., and Alexander, N. J. Do fertility drugs cause ovarian tumors? J Women's Health. 4, 247-259 (1995).